MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4143/crt.2023.616

Медицинская библиотека · Cancer research and treatment · 2023

Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814).

Park Younghee, Kim Tae Hyun, Kim Kyubo, Yu Jeong Il, Jung Wonguen, Seong Jinsil, Kim Woo Chul, Choi Jin Hwa, Chang Ah Ram, Jeong Bae Kwon, Kim Byoung Hyuck, Kim Tae Gyu, Kim Jin Hee, Park Hae Jin, Shin Hyun Soo, Im Jung Ho, Chie Eui Kyu

СтатьяПеревод в очереди

Аннотация

PURPOSE: Risk factors predicting distant metastasis (DM) in extrahepatic bile duct cancer (EHBDC) patients treated with curative resection were investigated.

MATERIALS AND

METHODS

Medical records of 1,418 EHBDC patients undergoing curative resection between Jan 2000 and Dec 2015 from 14 institutions were reviewed. After resection, 924 patients (67.6%) were surveilled without adjuvant therapy, 297 (21.7%) were treated with concurrent chemoradiotherapy (CCRT) and 148 (10.8%) with CCRT followed by chemotherapy. To exclude the treatment effect from innate confounders, patients not treated with adjuvant therapy were evaluated.

RESULTS

After a median follow-up of 36.7 months (range, 2.7 to 213.2 months), the 5-year distant metastasis-free survival (DMFS) rate was 57.7%. On multivariate analysis, perihilar or diffuse tumor (hazard ratio [HR], 1.391; p=0.004), poorly differentiated histology (HR, 2.014; p < 0.001), presence of perineural invasion (HR, 1.768; p < 0.001), positive nodal metastasis (HR, 2.670; p < 0.001) and preoperative carbohydrate antigen (CA) 19-9 ≥ 37 U/mL (HR, 1.353; p < 0.001) were significantly associated with inferior DMFS. The DMFS rates significantly differed according to the number of these risk factors. For validation, patients who underwent adjuvant therapy were evaluated. In patients with ≥ 3 factors, additional chemotherapy after CCRT resulted in a superior DMFS compared with CCRT alone (5-year rate, 47.6% vs. 27.7%; p=0.001), but the benefit of additional chemotherapy was not observed in patients with 0-2 risk factors.

CONCLUSION

Tumor location, histologic differentiation, perineural invasion, lymph node metastasis, and preoperative CA 19-9 level predicted DM risk in resected EHBDC. These risk factors might help identifying a subset of patients who could benefit from additional chemotherapy after resection.

Для цитирования: Park Younghee, Kim Tae Hyun, Kim Kyubo, Yu Jeong Il, Jung Wonguen, Seong Jinsil, Kim Woo Chul, Choi Jin Hwa, Chang Ah Ram, Jeong Bae Kwon, Kim Byoung Hyuck, Kim Tae Gyu, Kim Jin Hee, Park Hae Jin, Shin Hyun Soo, Im Jung Ho, Chie Eui Kyu. Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814).. Cancer research and treatment. 2023. DOI: 10.4143/crt.2023.616.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.